|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Centocor Inc., of Malvern, Pa., and Schering-Plough Corp., of Kenilworth, N.J., said data reported at the European League Against Rheumatism annual congress showed that patients treated with Remicade (infliximab) and methotrexate had better bone erosion scores than those treated solely with methotrexate. Specifically, more than 55 percent of combination patients demonstrated improvement, compared with 26.8 percent for methotrexate alone in early rheumatoid arthritis patients with progressive disease and bone erosions. Centocor is a wholly owned subsidiary of Johnson & Johnson, of New Brunswick, N.J.
o Dendreon Corp., of Seattle, named Richard Brewer chairman ...
Related newspaper, magazine, and journal articles:
|
|
Article: United States: New Brunswick: small business big ...
TendersInfo;
June 6, 2008 ;
566 words
... ... into big business in New Brunswick. With residential and ... 000 people. In fact, New Brunswick was top in Atlantic Canada ... trailed only Alberta, British Columbia and Quebec in job growth in 2007. New Brunswick's unemployment rate ...
|
|